New Insights into the Interactions Between T-cell Costimulatory Blockade and Conventional Immunosuppressive Drugs
Overview
Authors
Affiliations
Objective: To determine the precise in vivo interaction between T-cell costimulatory blockade and conventional immunosuppression in transplantation.
Summary Background Data: Blocking B7 or CD154 T-cell costimulatory activation pathways prevents allograft rejection in small and large animal transplant models and is considered a promising strategy for clinical organ transplantation.
Methods: A fully MHC-mismatched vascularized mouse cardiac allograft model was used to test the interactions between anti-CD154 or CTLA4Ig monotherapy and conventional immunosuppressive drugs in promoting long-term graft acceptance. The frequency of alloreactive T cell was measured by ELISPOT. Chronic rejection was examined by histology.
Results: Cyclosporine, tacrolimus, and anti-IL-2R monoclonal antibody therapy abrogated the effect of a single-dose protocol of anti-CD154 therapy. In contrast, rapamycin acted synergistically with anti-CD154 therapy in promoting long-term allograft survival. The addition of calcineurin inhibitors did not abolish this synergistic effect. Intense CD154-CD40 blockade by a multiple-dose schedule of anti-CD154 resulted in long-term graft survival and profound alloreactive T-cell unresponsiveness and overcame the opposite effects of calcineurin inhibitors. CTLA4Ig induced long-term graft survival, and the effect was not affected by the concomitant use of any immunosuppressive drugs.
Conclusions: The widespread view that calcineurin inhibitors abrogate the effects of T-cell costimulatory blockade should be revisited. Sufficient costimulatory blockade and synergy induced by CD154 blockade and rapamycin promote allograft tolerance and prevent chronic rejection.
Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft Survival.
Schonberg A, Hamdorf M, Bock F J Clin Med. 2020; 9(5).
PMID: 32354200 PMC: 7287922. DOI: 10.3390/jcm9051280.
Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.
Zhao L, Fu Z J Immunol Res. 2018; 2018:5301548.
PMID: 29854842 PMC: 5964556. DOI: 10.1155/2018/5301548.
Nuclear calcium is required for human T cell activation.
Monaco S, Jahraus B, Samstag Y, Bading H J Cell Biol. 2016; 215(2):231-243.
PMID: 27810914 PMC: 5084645. DOI: 10.1083/jcb.201602001.
Abdoli R, Najafian N Int J Organ Transplant Med. 2014; 5(3):97-110.
PMID: 25184030 PMC: 4149737.
Magee C, Boenisch O, Najafian N Am J Transplant. 2012; 12(10):2588-600.
PMID: 22759274 PMC: 3459149. DOI: 10.1111/j.1600-6143.2012.04180.x.